Smoliga JM, Blanchard O. Enhancing the delivery of resveratrol in humans: if low bioavailability is the problem, what is the solution? Molecules. 2014;19(11):17154–72. https://pubmed.ncbi.nlm.nih.gov/25347459/

1856

Pezzuto JM. Resveratrol: twenty years of growth, development and controversy. Biomol Ther (Seoul). 2019;27(1):1–14. https://pubmed.ncbi.nlm.nih.gov/30332889/

1857

Singh CK, Liu X, Ahmad N. Resveratrol, in its natural combination in whole grape, for health promotion and disease management. Ann N Y Acad Sci. 2015;1348(1):150–60. https://pubmed.ncbi.nlm.nih.gov/26099945/

1858

Сравнительно низкий уровень сердечно-сосудистых и онкологических заболеваний у жителей Франции при высококалорийном рационе питания и обилии в нем жиров. – Примеч. ред.

1859

Visioli F, Panaite SA, Tomé-Carneiro J. Wine’s phenolic compounds and health: a Pythagorean view. Molecules. 2020;25(18):4105. https://pubmed.ncbi.nlm.nih.gov/32911765/

1860

Burr ML. Explaining the French paradox. J R Soc Health. 1995;115(4):217–9. https://pubmed.ncbi.nlm.nih.gov/7562866/

1861

Vang O. What is new for resveratrol? Is a new set of recommendations necessary? Ann N Y Acad Sci. 2013;1290:1–11. https://pubmed.ncbi.nlm.nih.gov/23855460/

1862

Resveratrol. National Library of Medicine. https://pubmed.ncbi.nlm.nih.gov/?term=resveratrol. Accessed January 18, 2023.; https://pubmed.ncbi.nlm.nih.gov/?term=resveratrol

1863

Hector KL, Lagisz M, Nakagawa S. The effect of resveratrol on longevity across species: a meta-analysis. Biol Lett. 2012;8(5):790–3. https://pubmed.ncbi.nlm.nih.gov/22718956/

1864

Rascón B, Hubbard BP, Sinclair DA, Amdam GV. The lifespan extension effects of resveratrol are conserved in the honey bee and may be driven by a mechanism related to caloric restriction. Aging (Albany NY). 2012;4(7):499–508. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3433935/

1865

Hector KL, Lagisz M, Nakagawa S. The effect of resveratrol on longevity across species: a meta-analysis. Biol Lett. 2012;8(5):790–3. https://pubmed.ncbi.nlm.nih.gov/22718956/

1866

Kim E, Ansell CM, Dudycha JL. Resveratrol and food effects on lifespan and reproduction in the model crustacean Daphnia. J Exp Zool A Ecol Genet Physiol. 2014;321(1):48–56. https://pubmed.ncbi.nlm.nih.gov/24133070/

1867

Hector KL, Lagisz M, Nakagawa S. The effect of resveratrol on longevity across species: a meta-analysis. Biol Lett. 2012;8(5):790–3. https://pubmed.ncbi.nlm.nih.gov/22718956/

1868

Pacholec M, Bleasdale JE, Chrunyk B, et al. SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1. J Biol Chem. 2010;285(11):8340–51. https://pubmed.ncbi.nlm.nih.gov/20061378/

1869

Cottart CH, Nivet-Antoine V, Beaudeux JL. Is resveratrol an imposter? Mol Nutr Food Res. 2015;59(1):7. https://pubmed.ncbi.nlm.nih.gov/25558005/

1870

Tang PCT, Ng YF, Ho S, Gyda M, Chan SW. Resveratrol and cardiovascular health – promising therapeutic or hopeless illusion? Pharmacol Res. 2014;90:88–115. https://pubmed.ncbi.nlm.nih.gov/25151891/

1871

Артефакт эксперимента (от лат. arte – «искусственно» + factus – «сделанный») – эффект в эксперименте, возникающий вследствие дефектов методики проведения опыта. – Примеч. ред.

1872

Visioli F. The resveratrol fiasco. Pharmacol Res. 2014;90:87. https://pubmed.ncbi.nlm.nih.gov/25180457/

1873

Roehr B. Cardiovascular researcher fabricated data in studies of red wine. BMJ. 2012;344:e406. https://pubmed.ncbi.nlm.nih.gov/22250221/

1874

Visioli F. The resveratrol fiasco. Pharmacol Res. 2014;90:87. https://pubmed.ncbi.nlm.nih.gov/25180457/

1875

Resveratrol clinical trial, humans from 2014/12/1–3000/12/12. National Library of Medicine. https://pubmed.ncbi.nlm.nih.gov/?term=resveratrol&filter=pubt.clinicaltrial&filter=dates.2014%2F12%2F1–3000%2F12%2F12&filter=hum_ani.humans. Accessed January 18, 2023.; https://pubmed.ncbi.nlm.nih.gov/?term=resveratrol&filter=pubt.clinicaltrial&filter=dates.2014%2F12%2F1-3000%2F12%2F12&filter=hum_ani.humans

1876

Rabassa M, Zamora-Ros R, Urpi-Sarda M, et al. Association of habitual dietary resveratrol exposure with the development of frailty in older age: the Invecchiare in Chianti study. Am J Clin Nutr. 2015;102(6):1534–42. https://pubmed.ncbi.nlm.nih.gov/26490492/

1877

Semba RD, Ferrucci L, Bartali B, et al. Resveratrol levels and all-cause mortality in older community-dwelling adults. JAMA Intern Med. 2014;174(7):1077–84. https://pubmed.ncbi.nlm.nih.gov/24819981/

1878

Omidian M, Abdolahi M, Daneshzad E, et al. The effects of resveratrol on oxidative stress markers: a systematic review and meta-analysis of randomized clinical trials. Endocr Metab Immune Disord Drug Targets. 2020;20(5):718–27. https://pubmed.ncbi.nlm.nih.gov/31738139/

1879

Koushki M, Lakzaei M, Khodabandehloo H, Hosseini H, Meshkani R, Panahi G. Therapeutic effect of resveratrol supplementation on oxidative stress: a systematic review and meta-analysis of randomised controlled trials. Postgrad Med J. 2020;96(1134):197–205. https://pubmed.ncbi.nlm.nih.gov/31628212/

1880

Heger A, Ferk F, Nersesyan A, et al. Intake of a resveratrol-containing dietary supplement has no impact on DNA stability in healthy subjects. Mutat Res. 2012;749(1–2):82–6. https://pubmed.ncbi.nlm.nih.gov/22981768/

1881

Zeraattalab-Motlagh S, Jayedi A, Shab-Bidar S. The effects of resveratrol supplementation in patients with type 2 diabetes, metabolic syndrome, and nonalcoholic fatty liver disease: an umbrella review of meta-analyses of randomized controlled trials. Am J Clin Nutr. 2021;114(5):1675–85. https://pubmed.ncbi.nlm.nih.gov/34320173/

1882

Zhang T, He Q, Liu Y, Chen Z, Hu H. Efficacy and safety of resveratrol supplements on blood lipid and blood glucose control in patients with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials. Evid Based Complement Alternat Med. 2021;2021:5644171. https://pubmed.ncbi.nlm.nih.gov/34484395/

1883

Zeraattalab-Motlagh S, Jayedi A, Shab-Bidar S. The effects of resveratrol supplementation in patients with type 2 diabetes, metabolic syndrome, and nonalcoholic fatty liver disease: an umbrella review of meta-analyses of randomized controlled trials. Am J Clin Nutr. 2021;114(5):1675–8. https://pubmed.ncbi.nlm.nih.gov/34320173/

1884

Bashmakov YK, Assaad-Khalil SH, Abou Seif M, et al. Resveratrol promotes foot ulcer size reduction in type 2 diabetes patients. ISRN Endocrinol. 2014;2014:816307. https://pubmed.ncbi.nlm.nih.gov/24701359/

1885

Moxey PW, Gogalniceanu P, Hinchliffe RJ, et al. Lower extremity amputations – a review of global variability in incidence. Diabet Med. 2011;28(10):1144–53. https://pubmed.ncbi.nlm.nih.gov/21388445/

1886

Bhattarai G, Poudel SB, Kook SH, Lee JC. Resveratrol prevents alveolar bone loss in an experimental rat model of periodontitis. Acta Biomater. 2016;29:398–408. https://pubmed.ncbi.nlm.nih.gov/26497626/

1887

Zhen L, Fan DS, Zhang Y, Cao XM, Wang LM. Resveratrol ameliorates experimental periodontitis in diabetic mice through negative regulation of TLR4 signaling. Acta Pharmacol Sin. 2015;36(2):221–8. https://pubmed.ncbi.nlm.nih.gov/25530164/

1888